Conversation

Notices

1. Ars Technica (arstechnica@mastodon.social)'s status on Friday, 15-Dec-2023 08:00:52 JST Ars Technica

   MDMA—aka ecstasy—submitted to FDA as part of PTSD therapy

   If FDA approved, it would require the DEA to reclassify MDMA.

   https://arstechnica.com/science/2023/12/mdma-aka-ecstasy-submitted-to-fda-as-part-of-ptsd-therapy/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

   • 1 Fuckering Light (monsoonrains@mastodon.social)'s status on Friday, 15-Dec-2023 08:17:43 JST 1 Fuckering Light

     in reply to

     @arstechnica About fucking time.

   • Sandhu (sandhu@mastodon.social)'s status on Friday, 15-Dec-2023 08:49:41 JST Sandhu

     in reply to

     @arstechnica Hope it gets quick approval. It really does work for most people.

   • airjunglist (airjunglist@mastodon.social)'s status on Friday, 15-Dec-2023 09:14:45 JST airjunglist

     in reply to

     @arstechnica maybe stop giving everyone PTSD instead?

   • 🌚JR🌝 (jgr0@mastodon.social)'s status on Friday, 15-Dec-2023 10:13:33 JST 🌚JR🌝

     in reply to

     @arstechnica Can’t wait for the DEA to faff about for 20 more years while they attempt to keep government control over a substance known to help people, like they did with cannabis.